Novartis Bone Drug Suit Grows
Novartis Pharmaceutical Corp.'s litigation woes have worsened, with 11 new product liability suits added this week to the multidistrict case over the drug maker's bone cancer medications....To view the full article, register now.
Already a subscriber? Click here to view full article